{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:32Z","timestamp":1792205012265,"version":"4.4.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bioorg.2025.108224","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:01:31Z","timestamp":1738206091000},"page":"108224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Carbonic anhydrase inhibitors: Structural insights and therapeutic potential"],"prefix":"10.1016","volume":"156","author":[{"given":"Priti","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar Goud","family":"Nerella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0005","doi-asserted-by":"crossref","DOI":"10.1124\/pharmrev.124.001125","article-title":"Multi- and Polypharmacology of Carbonic Anhydrase Inhibitors","volume":"77","author":"Supuran","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108224_b0015","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/13543776.2019.1629419","article-title":"Carbonic Anhydrases as Disease Markers","volume":"29","author":"Zamanova","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2025.108224_b0025","article-title":"Tumor Associated Carbonic Anhydrase Inhibitors: Rational Approaches, Design Strategies, Structure Activity Relationship and Mechanistic Insights","volume":"10","author":"Nerella","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108224_b0030","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the Development of Human Carbonic Anhydrase Inhibitors and Their Pharmacological Applications: Where Are We Today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"40","key":"10.1016\/j.bioorg.2025.108224_b0035","doi-asserted-by":"crossref","first-page":"12391","DOI":"10.1021\/bi000937c","article-title":"Mechanism of Cyanamide Hydration Catalyzed by Carbonic Anhydrase II Suggested by Cryogenic X-Ray Diffraction","volume":"39","author":"Guerri","year":"2000","journal-title":"Biochemistry"},{"issue":"23","key":"10.1016\/j.bioorg.2025.108224_b0040","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1021\/ja00951a049","article-title":"The Catalytic Versatility of Erythrocyte Carbonic Anhydrase. The Enzyme-Catalyzed Hydrolysis of Rho-Nitrophenyl Acetate","volume":"87","author":"Pocker","year":"1965","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0134(199702)27:2<272::AID-PROT12>3.0.CO;2-J","article-title":"Is Cyanate a Carbonic Anhydrase Substrate?","volume":"27","author":"Supuran","year":"1997","journal-title":"Proteins"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic Anhydrases\u2013an Overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108224_b0055","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.3390\/molecules26237331","article-title":"Amine- and Amino Acid-Based Compounds as Carbonic Anhydrase Activators","volume":"26","author":"Angeli","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/14756366.2012.737323","article-title":"Structural Annotation of Human Carbonic Anhydrases","volume":"28","author":"Aggarwal","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108224_b0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/13543776.2022.2083502","article-title":"Anticancer Carbonic Anhydrase Inhibitors: A Patent and Literature Update 2018-2022","volume":"32","author":"Nerella","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0070","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbapap.2009.07.025","article-title":"Sequestration of Carbon Dioxide by the Hydrophobic Pocket of the Carbonic Anhydrases","volume":"1804","author":"Domsic","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0075","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the Hydrophobic and Hydrophilic Binding Sites for Designing Carbonic Anhydrase Inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0080","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","article-title":"Activation of \u03b1-, \u03b2-, \u03b3- \u03b4-, \u03b6- and \u03b7- Class of Carbonic Anhydrases with Amines and Amino Acids: A Review","volume":"34","author":"Akocak","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.plantsci.2017.12.002","article-title":"The Many Types of Carbonic Anhydrases in Photosynthetic Organisms","volume":"268","author":"DiMario","year":"2018","journal-title":"Plant Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0090","doi-asserted-by":"crossref","first-page":"15456","DOI":"10.3390\/ijms160715456","article-title":"Thermostable Carbonic Anhydrases in Biotechnological Applications","volume":"16","author":"Di Fiore","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108224_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104272","article-title":"Synthesis and Biological Evaluation of Some Coumarin Hybrids as Selective Carbonic Anhydrase IX and XII Inhibitors","volume":"104","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106399","article-title":"PET Radiotracers and Fluorescent Probes for Imaging Human Carbonic Anhydrase IX and XII in Hypoxic Tumors","volume":"133","author":"Nerella","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0105","series-title":"Carbonic Anhydrases as Biocatalysts","first-page":"17","article-title":"Human Carbonic Anhydrases: Catalytic Properties, Structural Features, and Tissue Distribution","author":"D\u2019Ambrosio","year":"2015"},{"key":"10.1016\/j.bioorg.2025.108224_b0110","series-title":"Carbonic Anhydrases","first-page":"151","article-title":"Human Carbonic Anhydrases","author":"Nocentini","year":"2019"},{"key":"10.1016\/j.bioorg.2025.108224_b0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2091-11-28","article-title":"Characterization of the First Beta-Class Carbonic Anhydrase from an Arthropod (Drosophila Melanogaster) and Phylogenetic Analysis of Beta-Class Carbonic Anhydrases in Invertebrates","volume":"11","author":"Syrj\u00e4nen","year":"2010","journal-title":"BMC Biochem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbapap.2009.08.002","article-title":"Structure and Catalytic Mechanism of the \u03b2-Carbonic Anhydrases","volume":"1804","author":"Rowlett","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA) - P Proteins and Proteomics"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0125","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbapap.2009.08.026","article-title":"The Gamma Class of Carbonic Anhydrases","volume":"1804","author":"Ferry","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2025.108224_b0130","doi-asserted-by":"crossref","unstructured":"Santiago-Mart\u00ednez, M. G.; Zimmerman, S.; Apolinario, E. E.; Sowers, K. R.; Ferry, J. G. Carbonic Anhydrase Plays Multiple Roles in Acetotrophic Growth of a Model Marine Methanogen from the Domain Archaea. April 24, 2024.","DOI":"10.1101\/2024.04.24.590269"},{"key":"10.1016\/j.bioorg.2025.108224_b0135","series-title":"Carbonic Anhydrases as Biocatalysts","first-page":"337","article-title":"\u03b4-Carbonic Anhydrases: Structure, Distribution, and Potential Roles","author":"Beauchemin","year":"2015"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/14756366.2019.1571273","article-title":"Inhibition of \u03b1-, \u03b2-, \u03b3-, \u03b4-, \u03b6- and \u03b7-Class Carbonic Anhydrases from Bacteria, Fungi, Algae, Diatoms and Protozoans with Famotidine","volume":"34","author":"Angeli","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"35","key":"10.1016\/j.bioorg.2025.108224_b0145","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1073\/pnas.1603112113","article-title":"Thylakoid Luminal \u03b8-Carbonic Anhydrase Critical for Growth and Photosynthesis in the Marine Diatom Phaeodactylum Tricornutum","volume":"113","author":"Kikutani","year":"2016","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/14756366.2018.1559840","article-title":"Phaeodactylum Tricornutum as a Model Organism for Testing the Membrane Penetrability of Sulphonamide Carbonic Anhydrase Inhibitors","volume":"34","author":"Rogato","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0155","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/14756366.2021.1972995","article-title":"An Overview on the Recently Discovered Iota-Carbonic Anhydrases","volume":"36","author":"Nocentini","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108224_b0160","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41396-019-0426-8","article-title":"A New Widespread Subclass of Carbonic Anhydrase in Marine Phytoplankton","volume":"13","author":"Jensen","year":"2019","journal-title":"ISME J."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How Many Carbonic Anhydrase Inhibition Mechanisms Exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0170","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon- versus Sulphur-Based Zinc Binding Groups for Carbonic Anhydrase Inhibitors?","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128809","article-title":"Synthesis of a New Series of Quinoline\/Pyridine Indole-3-Sulfonamide Hybrids as Selective Carbonic Anhydrase IX Inhibitors","volume":"70","author":"Singh","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0180","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","article-title":"Coumarin Carbonic Anhydrase Inhibitors from Natural Sources","volume":"35","author":"Supuran","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108224_b0185","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/molecules23051045","article-title":"Cancer Drug Development of Carbonic Anhydrase Inhibitors beyond the Active Site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.bioorg.2025.108224_b0190","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3390\/molecules24193580","article-title":"Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation","volume":"24","author":"Kartsev","year":"2019","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0195","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple Binding Modes of Inhibitors to Human Carbonic Anhydrases: An Update on the Design of Isoform-Specific Modulators of Activity","volume":"125","author":"D\u2019Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1039\/C4CC07320G","article-title":"Out of the Active Site Binding Pocket for Carbonic Anhydrase Inhibitors","volume":"51","author":"D\u2019Ambrosio","year":"2015","journal-title":"Chem. Commun."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108224_b0205","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.bmc.2007.04.020","article-title":"Carbonic Anhydrases as Targets for Medicinal Chemistry","volume":"15","author":"Supuran","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108224_b0210","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging Role of Carbonic Anhydrase Inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0215","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-Classical Inhibition of Carbonic Anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"29","key":"10.1016\/j.bioorg.2025.108224_b0220","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1002\/slct.202102082","article-title":"Transition\u2010Metal Complexes of Bidentate Schiff\u2010Base Ligands: In Vitro and In Silico Evaluation as Non\u2010Classical Carbonic Anhydrase and Potential Acetylcholinesterase Inhibitors","volume":"6","author":"Ya\u015far","year":"2021","journal-title":"ChemistrySelect"},{"issue":"22","key":"10.1016\/j.bioorg.2025.108224_b0225","first-page":"1935","article-title":"Novel Carbonic Anhydrase Inhibitors. Future","volume":"13","author":"Supuran","year":"2021","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0230","series-title":"Serum Pharmacochemistry of Traditional Chinese Medicine","first-page":"7","article-title":"Serum Pharmacochemistry of Traditional Chinese Medicine","author":"Wang","year":"2017"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108224_b0235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and Their Isosters as Carbonic Anhydrase Inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112923","article-title":"Recent Advances in the Medicinal Chemistry of Carbonic Anhydrase Inhibitors","volume":"209","author":"Kumar","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0245","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-94-007-7359-2_17","article-title":"Glaucoma and the Applications of Carbonic Anhydrase Inhibitors","volume":"75","author":"Scozzafava","year":"2014","journal-title":"Subcell. Biochem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/jcm8030349","article-title":"Acetazolamide Therapy in Patients with Heart Failure: A Meta-Analysis","volume":"8","author":"Wongboonsin","year":"2019","journal-title":"JCM"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/jop.2008.0114","article-title":"A Comparison of the Long-Term Effects of Dorzolamide 2% and Brinzolamide 1%, Each Added to Timolol 0.5%, on Retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients","volume":"25","author":"Mart\u00ednez","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0260","first-page":"174","article-title":"Diclofenamide in the Treatment of Therapy-Resistant Epilepsy","volume":"78","author":"Rucquoy","year":"1978","journal-title":"Acta Neurol. Belg."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0265","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1080\/14756366.2019.1663416","article-title":"Anti-Helicobacter Pylori Activity of Ethoxzolamide","volume":"34","author":"Modak","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.574652","article-title":"Zonisamide for the Treatment of Parkinson Disease: A Current Update","volume":"14","author":"Li","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0275","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.12.2.283","article-title":"Indisulam: An Anticancer Sulfonamide in Clinical Development","volume":"12","author":"Supuran","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0280","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/14756366.2022.2053526","article-title":"The Three-Tails Approach as a New Strategy to Improve Selectivity of Action of Sulphonamide Inhibitors against Tumour-Associated Carbonic Anhydrase IX and XII","volume":"37","author":"Bonardi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0285","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic Anhydrase Inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2025.108224_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105920","article-title":"A Decade of Tail-Approach Based Design of Selective as Well as Potent Tumor Associated Carbonic Anhydrase Inhibitors","volume":"126","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0295","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1517\/17460441.2015.1000857","article-title":"Discovery of Novel Inhibitors for the Treatment of Glaucoma","volume":"10","author":"Cholkar","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0300","first-page":"233","article-title":"Recent Advancements on Biological Activity of Indole and Their Derivatives: A Review","volume":"46","author":"Kumar","year":"2022","journal-title":"Thai Jo. Pharmaceut. Sci."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108224_b0305","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.3390\/molecules28145477","article-title":"Indole Derivatives: Unveiling New Frontiers in Medicinal and Synthetic Organic Chemistry","volume":"28","author":"Saleem","year":"2023","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108224_b0310","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3390\/ijms23052540","article-title":"Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies","volume":"23","author":"Elkamhawy","year":"2022","journal-title":"IJMS"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108224_b0315","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3390\/ijms20092354","article-title":"Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII","volume":"20","author":"Demir-Yaz\u0131c\u0131","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108224_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103839","article-title":"Synthesis and Carbonic Anhydrase Inhibition Studies of Sulfonamide Based Indole-1,2,3-Triazole Chalcone Hybrids","volume":"99","author":"Singh","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108224_b0325","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/1871520623666230227092821","article-title":"Development of Novel Indole-3-Sulfonamide-Heteroaryl Hybrids as CarbonicAnhydrase Inhibitors: Design Synthesis and in-Vitro Screening","volume":"23","author":"Chinchilli","year":"2023","journal-title":"ACAMC"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108224_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200023","article-title":"New 1 H \u2010indole\u20102,3\u2010dione 3\u2010thiosemicarbazones with 3\u2010sulfamoylphenyl Moiety as Selective Carbonic Anhydrase Inhibitors","volume":"355","author":"Eraslan-Elma","year":"2022","journal-title":"Arch. Pharm."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0335","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1515\/hc-2020-0008","article-title":"Coumarin Sulfonamide Derivatives: An Emerging Class of Therapeutic Agents","volume":"26","author":"Irfan","year":"2020","journal-title":"Heterocycl. Commun."},{"issue":"14","key":"10.1016\/j.bioorg.2025.108224_b0340","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1021\/acs.jmedchem.5b00969","article-title":"Correction to Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins","volume":"58","author":"Maresca","year":"2015","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108224_b0345","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.3390\/molecules27134076","article-title":"Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII","volume":"27","author":"Giovannuzzi","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0350","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/14756366.2020.1712596","article-title":"Sulfocoumarins as Dual Inhibitors of Human Carbonic Anhydrase Isoforms IX\/XII and of Human Thioredoxin Reductase","volume":"35","author":"Krasavin","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108224_b0355","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202100725","article-title":"Ureidosulfocoumarin Derivatives As Selective and Potent Carbonic Anhydrase IX and XII Inhibitors","volume":"17","author":"Singh","year":"2022","journal-title":"ChemMedChem"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108224_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115586","article-title":"New Coumarin\/Sulfocoumarin Linked Phenylacrylamides as Selective Transmembrane Carbonic Anhydrase Inhibitors: Synthesis and in-Vitro Biological Evaluation","volume":"28","author":"Swain","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0365","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s43094-021-00241-3","article-title":"Triazole Analogues as Potential Pharmacological Agents: A Brief Review","volume":"7","author":"Kumar","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108224_b0370","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4155\/fmc-2023-0321","article-title":"Novel 1,2,4-Triazoles as Selective Carbonic Anhydrase Inhibitors Showing Ancillary Anticathepsin B Activity","volume":"16","author":"Kumar","year":"2024","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0375","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-Benzoxathiine-2,2-Dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108224_b0380","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cmdc.201700446","article-title":"Sulfocoumarin\u2010, Coumarin\u2010, 4\u2010Sulfamoylphenyl\u2010Bearing Indazole\u20103\u2010carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor\u2010Associated Carbonic Anhydrase Isozymes IX and XII","volume":"12","author":"Angapelly","year":"2017","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0385","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/14756366.2019.1629432","article-title":"Synthesis of a New Series of 3-Functionalised-1-Phenyl-1,2,3-Triazole Sulfamoylbenzamides as Carbonic Anhydrase I, II, IV and IX Inhibitors","volume":"34","author":"Swain","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108224_b0390","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","article-title":"Azidothymidine \u201cClicked\u201d into 1,2,3-Triazoles: First Report on Carbonic Anhydrase\u2013Telomerase Dual-Hybrid Inhibitors","volume":"63","author":"Berrino","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124232","article-title":"Discovery of Novel Benzenesulfonamides Incorporating 1,2,3-Triazole Scaffold as Carbonic Anhydrase I, II, IX, and XII Inhibitors","volume":"239","author":"Buza","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108224_b0400","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0405","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejmech.2014.05.039","article-title":"Carbonic Anhydrase Inhibitors. Synthesis of a Novel Series of 5-Substituted 2,4-Dichlorobenzenesulfonamides and Their Inhibition of Human Cytosolic Isozymes I and II and the Transmembrane Tumor-Associated Isozymes IX and XII","volume":"82","author":"S\u0142awi\u0144ski","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0410","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2016.01.030","article-title":"Amido\/Ureidosubstituted Benzenesulfonamides-Isatin Conjugates as Low Nanomolar\/Subnanomolar Inhibitors of the Tumor-Associated Carbonic Anhydrase Isoform XII","volume":"110","author":"Eldehna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108224_b0415","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108224_b0420","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.bmc.2016.04.002","article-title":"Acetylcholinesterase and Carbonic Anhydrase Inhibitory Properties of Novel Urea and Sulfamide Derivatives Incorporating Dopaminergic 2-Aminotetralin Scaffolds","volume":"24","author":"\u00d6zgeri\u015f","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0425","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100333","article-title":"Design and Development of Novel Series of Indole\u20103\u2010sulfonamide Ureido Derivatives as Selective Carbonic Anhydrase II Inhibitors","volume":"355","author":"Singh","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108224_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113035","article-title":"Handling Drug-Target Selectivity: A Study on Ureido Containing Carbonic Anhydrase Inhibitors","volume":"212","author":"Akgul","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of Novel Benzofuran-Based SLC-0111 Analogs as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0440","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2022.2154603","article-title":"Discovery of New 6-Ureido\/Amidocoumarins as Highly Potent and Selective Inhibitors for the Tumour-Relevant Carbonic Anhydrases IX and XII","volume":"38","author":"El-Damasy","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108224_b0445","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1747-0285.2011.01104.x","article-title":"In Vitro Inhibition of Human Carbonic Anhydrase I and II Isozymes with Natural Phenolic Compounds","volume":"77","author":"\u015eent\u00fcrk","year":"2011","journal-title":"Chem. Biol. Drug Des."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108224_b0450","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ardp.201600122","article-title":"Synthesis and Biological Evaluation of Novel Bischalcone Derivatives as Carbonic Anhydrase Inhibitors","volume":"349","author":"Arslan","year":"2016","journal-title":"Arch. Pharm."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108224_b0455","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22281","article-title":"Evaluation of Antimicrobial, Antibiofilm and Carbonic Anhydrase Inhibition Profiles of 1,3\u2010bis\u2010chalcone Derivatives","volume":"33","author":"Tutar","year":"2019","journal-title":"J Biochem & Molecular Tox"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108224_b0460","article-title":"Comparison of the Inhibitory Potential towards Carbonic Anhydrase, Acetylcholinesterase and Butyrylcholinesterase of Chalcone and Chalcone Epoxide","volume":"33","author":"Stellenboom","year":"2019","journal-title":"J. Biochem. & Molecul. Tox."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0465","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","article-title":"Synthesis, Cytotoxicities, and Carbonic Anhydrase Inhibition Potential of 6-(3-Aryl-2-Propenoyl)-2(3H)-Benzoxazolones","volume":"34","author":"Bilginer","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0470","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bioorg.2018.12.035","article-title":"Synthesis and Biological Evaluation of Novel Tris-Chalcones as Potent Carbonic Anhydrase, Acetylcholinesterase Butyrylcholinesterase and \u03b1-Glycosidase Inhibitors","volume":"85","author":"Burmaoglu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104647","article-title":"Discovery of a Novel Series of Indolylchalcone-Benzenesulfonamide Hybrids Acting as Selective Carbonic Anhydrase II Inhibitors","volume":"108","author":"Singh","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0480","doi-asserted-by":"crossref","unstructured":"Matada, B. S.; Pattanashettar, R.; Yernale, N. G. Corrigendum to \u201cA Comprehensive Review on the Biological Interest of Quinoline and Its Derivatives\u201d [Bioorg. Med. Chem. 32 (2021) 115973]. Bioorg. Med. Chem. 2021, 37, 116098.","DOI":"10.1016\/j.bmc.2021.116098"},{"issue":"29","key":"10.1016\/j.bioorg.2025.108224_b0485","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1039\/D2RA02896D","article-title":"Recent Advances in Chemistry and Therapeutic Potential of Functionalized Quinoline Motifs \u2013 a Review","volume":"12","author":"Ajani","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.108224_b0490","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.2147\/DDDT.S329547","article-title":"The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design","volume":"15","author":"Ling","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108224_b0495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/10408347.2022.2089839","article-title":"Medicinal Importance and Chemosensing Applications of Pyridine Derivatives: A Review","volume":"54","author":"Mohammad Abu-Taweel","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108224_b0500","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1080\/14756366.2019.1626376","article-title":"Synthesis and Biological Evaluation of Novel 8-Substituted Quinoline-2-Carboxamides as Carbonic Anhydrase Inhibitors","volume":"34","author":"Thacker","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108224_b0505","doi-asserted-by":"crossref","first-page":"11119","DOI":"10.3390\/ijms222011119","article-title":"Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors","volume":"22","author":"Shaldam","year":"2021","journal-title":"IJMS"},{"key":"10.1016\/j.bioorg.2025.108224_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114247","article-title":"Exploration of 2-Phenylquinoline-4-Carboxamide Linked Benzene Sulfonamide Derivatives as Isoform Selective Inhibitors of Transmembrane Human Carbonic Anhydrases","volume":"234","author":"Swain","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0515","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejmech.2013.09.027","article-title":"Carbonic Anhydrase Inhibitors. Synthesis of Heterocyclic 4-Substituted Pyridine-3-Sulfonamide Derivatives and Their Inhibition of the Human Cytosolic Isozymes I and II and Transmembrane Tumor-Associated Isozymes IX and XII","volume":"69","author":"S\u0142awi\u0144ski","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103153","article-title":"Synthesis, Molecular Docking Analysis and Carbonic Anhydrase I-II Inhibitory Evaluation of New Sulfonamide Derivatives","volume":"91","author":"Sa\u011fl\u0131k","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108224_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112300","article-title":"Development of Oxathiino[6,5-b]Pyridine 2,2-Dioxide Derivatives as Selective Inhibitors of Tumor-Related Carbonic Anhydrases IX and XII","volume":"200","author":"Grand\u0101ne","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T02:06:11Z","timestamp":1758852371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":105,"alternative-id":["S004520682500104X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108224","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase inhibitors: Structural insights and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108224"}}